The 20 Best Multicentric Castleman Disease (MCD) Doctors Near Me in burleson, TX
Find the Top Multicentric Castleman Disease (MCD) Experts and Specialists
The Center For Cancer And Blood Disorders
Vinaya Potluri is an Oncologist and a Hematologist practicing medicine in Burleson, Texas. Dr. Potluri is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Anemia. Dr. Potluri is board certified in Medical Oncology- American Board Of Internal Medicine and Medical Oncology- American Board Of Internal Med/Medical Oncology. Dr. Potluri is currently accepting new patients.
Legend Internal Medicine Urgent Care & Diagnostics, PA
Fidelis Unini is a primary care provider, practicing in Internal Medicine in Fort Worth, Texas. Dr. Unini is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Muscle Atrophy, Familial Hypertension, Gastrostomy, and Endoscopy. Dr. Unini is board certified in Internal Medicine- American Board Of Internal Med and Internal Medicine- American Board Of Internal Medicine. Dr. Unini is currently accepting new patients.
Office
James Parker is a primary care provider, practicing in Internal Medicine in Fort Worth, Texas. Dr. Parker is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hypertensive Heart Disease, Apparent Mineralocorticoid Excess, Familial Hyperaldosteronism, and Hyperaldosteronism. Dr. Parker is currently accepting new patients.
To see more doctors, please expand your search radius or view related conditions below.
Last Updated: 09/26/2026

